Diadema Partners’s Evolus EOLS Stock Holding History

Diadema Partners’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-97,423	Closed	-$1.27M	–	124
2024 Q4	$1.08M	Buy	+97,423	New	+$1.37M	0.46%	50

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diadema Partners's EOLS Position: Q1 2025 in Review

Diadema Partners sold out of Evolus (EOLS) in Q1 2025, closing a stake of 97,423 shares — an estimated $1.27M sold.

Diadema Partners first reported a position in EOLS in Q4 2024 and held it in 1 quarter. The position peaked at $1.08M in Q4 2024. 179 funds tracked by Wall St. Rank hold EOLS as of Q1 2025.

Diadema Partners reported no remaining Evolus position as of Q1 2025 after selling out during the quarter.
Diadema Partners sold 97,423 Evolus shares in Q1 2025, an estimated $1.27M.
Diadema Partners first reported a position in Evolus in Q4 2024 and held it in 1 quarter.
Diadema Partners's Evolus position peaked at $1.08M in Q4 2024.
179 funds tracked by Wall St. Rank held Evolus as of Q1 2025.

Based on Diadema Partners's 13F filing for Q1 2025, filed 15 May 2025.